Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Maxwell Mays"'
Autor:
Xiaolei Liu, Elizabeth J. Kopras, Yang Liu, Chenggang Li, Anya Alayev, David R. Plas, Erik Zhang, Kantha Medepalli, Kouhei Masuda, Brian J. Siroky, David J. Kwiatkowski, Yang Sun, Marina K. Holz, Julia Sun, David Neal Franz, Michael T. Borchers, Darcy A. Krueger, Jamie K. Capal, Kathryn A. Wikenheiser-Brokamp, Jane J. Yu, Andrew R. Osterburg, Na Li, Maxwell Mays
Publikováno v:
Molecular Cancer Research. 15:1318-1330
Tuberous sclerosis complex (TSC) is a tumor-suppressor syndrome affecting multiple organs, including the brain, skin, kidneys, heart, and lungs. TSC is associated with mutations in TSC1 or TSC2, resulting in hyperactivation of mTOR complex 1 (mTORC1)
Autor:
Nishant Gupta, Weiji Su, David Neal Franz, Francis X. McCormack, Sara Mary Zak, Maxwell Mays, Rhonda D. Szczesniak, Nadine Mokhallati, Darcy A. Krueger
Publikováno v:
Annals of the American Thoracic Society. 16(4)
Autor:
David Neal Franz, Karen Agricola, Darcy A. Krueger, Severine Peyrard, Katherine Holland‐Bouley, Maxwell Mays, Noah Berkowitz, Cindy Tudor, Sara Miao, Marguerite M. Care
Publikováno v:
Annals of Neurology
Objective To analyze the cumulative efficacy and safety of everolimus in treating subependymal giant cell astrocytomas (SEGA) associated with tuberous sclerosis complex (TSC) from an open-label phase II study (NCT00411619). Updated data became availa
Autor:
Jamie K. Capal, Karen Agricola, Maxwell Mays, David Neal Franz, Katherine Holland-Bouley, Cindy Tudor, Darcy Andrew Krueger, Christina M. Talley, Angus A. Wilfong
Publikováno v:
Neurology. 87(23)
Objective:To evaluate the long-term benefit and safety of everolimus for the treatment of medically refractory epilepsy in patients with tuberous sclerosis complex (TSC).Methods:Everolimus was titrated over 4 weeks and continued an additional 8 weeks
Autor:
Cindy Tudor, David Neal Franz, Marguerite M. Caré, Darcy A. Krueger, Maxwell Mays, Karen Agricola
Publikováno v:
Neurology. 80(6)
Objective: To report long-term efficacy and safety data for everolimus for the treatment of subependymal giant cell astrocytoma (SEGA) in patients with tuberous sclerosis complex (TSC). Methods: This was an open-label extension phase of a prospective
Publikováno v:
Archives of Surgery; October 1957, Vol. 75 Issue: 4 p625-630, 6p